Simultaneous splenectomy (SPX) is preferentially performed in living donor liver transplantation (LDLT) to modulate portal flow; increase postoperative platelet count, especially among those with hepatitis C virus (HCV) infection; and modulate the immunologic status in ABO-incompatible cases. The negative effects of the procedure, however, are not well established. Records of 395 LDLTs performed at our institution, including 169 (42.8%) patients with simultaneous SPX and 226 (57.2%) patients with spleen preservation, were reviewed with special reference to the simultaneous SPX cases. The most common indication for SPX was HCV-related disease (n = 114), followed by low preoperative platelet count (n = 52), and other reasons (n = 3). Simultaneous splenectomy did not increase the platelet count in the early postoperative period, but the incidence of reoperation for postoperative hemorrhage was increased, mainly at the SPX site, within the first week. In addition, the operative time, intraoperative blood loss, and incidence of lethal infectious disease were significantly higher in the SPX group, whereas the incidence of small-for-size syndrome was comparable between groups. Finally, SPX was an independent predictor for both postoperative hemorrhage (odds ratio [OR] = 2.451; 95% confidence interval [CI] = 1.285-4.815; P = 0.006) and lethal infectious complication (OR = 3.748; 95% CI = 1.148-14.001; P = 0.03). In conclusion, on the basis of the present findings, we do not recommend simultaneous SPX in LDLT. Liver Transplantation 22 1526-1535 2016 AASLD.
Defects in ion-implanted GaN and their annealing properties were studied by using monoenergetic positron beams. Doppler broadening spectra of the annihilation radiation and the positron lifetimes were measured for Si+, O+, and Be+-implanted GaN grown by the metal-organic chemical vapor deposition technique. First-principles calculations were also used to identify defect species introduced by the implantation. For as-implanted samples, the major defect species was identified as Ga vacancies and/or divacancies. An agglomeration of defects starts after annealing at 400 °C, and the defect profile shifted toward the surface with the open volumes of the defects increasing. The annealing properties of defects were found to depend on the ion species, and they are discussed here in terms of defect concentrations and interactions between impurities and defects.
We consider the discrete one-dimensional Schrödinger operatorand V is a self-adjoint operator on ℓ 2 (Z) with a decay property given by V extending to a compact operator from ℓ ∞,−β (Z) to ℓ 1,β (Z) for some β ≥ 1. We give a complete description of the solutions to Hx = 0, and Hx = 4x, x ∈ ℓ ∞,−β (Z). Using this description we give asymptotic expansions of the resolvent of H at the two thresholds 0 and 4. One of the main results is a precise correspondence between the solutions to Hx = 0 and the leading coefficients in the asymptotic expansion of the resolvent around 0. For the resolvent expansion we implement the expansion scheme of Jensen-Nenciu [4,5] in the full generality.
We construct a time‐dependent scattering theory for Schrödinger operators on a manifold M with asymptotically conic structure. We use the two‐space scattering theory formalism, and a reference operator on a space of the form ℝ×∂M, where ∂M is the boundary of M at infinity. We prove the existence and the completeness of the wave operators, and show that our scattering matrix is equivalent to the absolute scattering matrix, which is defined in terms of the asymptotic expansion of generalized eigenfunctions. Our method is functional analytic, and we use no microlocal analysis in this paper.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.